Literature DB >> 16217288

The independent impact of extended pattern biopsy on prostate cancer stage migration.

Viraj A Master1, Thomas Chi, Jeffrey P Simko, Vivian Weinberg, Peter R Carroll.   

Abstract

PURPOSE: There are many factors impacting stage migration for prostate cancer. The number of prostate core biopsies is known to increase detection of prostate cancers. It is still unknown whether the number of biopsies is an independent predictor of tumor size. This is important as a number of studies show that tumor volume is an independent predictor of cancer progression.
MATERIALS AND METHODS: Using the University of California, San Francisco Urologic Oncology database, a retrospective review of 378 patients undergoing radical prostatectomy by a single surgeon during 2000 to 2003 was performed. Patient and tumor specific variables including age, prostate specific antigen (PSA), number of biopsies, biopsy Gleason grade, tumor volume in the surgical specimen and surgical specimen tumor grade were studied. Univariate and multivariate statistical methods including multiple and logistic regression were used to characterize patients by the number of biopsy cores. Tests of significance to identify predictors of tumor size were based on the partial F statistic and the likelihood ratio test.
RESULTS: A total of 317 eligible patients were studied, of whom 119 had 6 biopsies and 198 had more than 6 biopsies. The 2 groups of patients were evenly matched in terms of age, PSA and Gleason sum, with no statistically significant differences observed. On univariate analysis, mean tumor volume was larger for patients receiving 6 core biopsies vs greater than 6 core biopsies (3.85 vs 2.04 cc, p = 0.0009). Additionally, statistically significant differences were observed when comparing median tumor volumes, as well as excluding extremely large volume tumors. On multivariate analysis the number of biopsies performed (6 vs more than 6), was an independent predictor of tumor size (p = 0.006), controlling for primary Gleason score, Gleason sum, PSA as a continuous or categorical variable, year of biopsy and year of surgery.
CONCLUSIONS: The use of extended pattern prostate biopsy templates results in the detection of smaller volume prostate cancers, independent of PSA and Gleason grade. These biopsy templates have contributed to the downward stage migration of prostate cancer detection and may possibly contribute to the risk of over detection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16217288     DOI: 10.1097/01.ju.0000177465.11299.02

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  10 in total

1.  Simulation optimization of PSA-threshold based prostate cancer screening policies.

Authors:  Daniel J Underwood; Jingyu Zhang; Brian T Denton; Nilay D Shah; Brant A Inman
Journal:  Health Care Manag Sci       Date:  2012-12

2.  Is repeat biopsy for isolated high-grade prostatic intraepithelial neoplasia necessary?

Authors:  Arnold I Chin; Dhiren S Dave; Jacob Rajfer
Journal:  Rev Urol       Date:  2007

3.  Using biopsy to detect prostate cancer.

Authors:  Shahrokh F Shariat; Claus G Roehrborn
Journal:  Rev Urol       Date:  2008

4.  The 20-core prostate biopsy as an initial strategy: impact on the detection of prostatic cancer.

Authors:  Mohamed Amine Jradi; Mohamed Dridi; Mourad Teyeb; Mokhtar Ould Sidi Mohamed; Ramzi Khiary; Samir Ghozzi; Nawfel Ben Rais
Journal:  Can Urol Assoc J       Date:  2010-04       Impact factor: 1.862

5.  Ex Vivo High-Resolution Magic Angle Spinning (HRMAS) 1H NMR Spectroscopy for Early Prostate Cancer Detection.

Authors:  Annabel Steiner; Stefan Andreas Schmidt; Cara Sophie Fellmann; Johannes Nowak; Chin-Lee Wu; Adam Scott Feldman; Meinrad Beer; Leo L Cheng
Journal:  Cancers (Basel)       Date:  2022-04-26       Impact factor: 6.575

Review 6.  What is low-risk prostate cancer and what is its natural history?

Authors:  Helen O'Donnell; Chris Parker
Journal:  World J Urol       Date:  2008-06-21       Impact factor: 4.226

Review 7.  Saturation biopsies for prostate cancer: current uses and future prospects.

Authors:  Nicolas B Delongchamps; Gabriel P Haas
Journal:  Nat Rev Urol       Date:  2009-11-10       Impact factor: 14.432

8.  Diagnostic accuracy of extended biopsies for the staging of microfocal prostate cancers in autopsy specimen.

Authors:  N B Delongchamps; G de la Roza; V Chandan; R Jones; G Threatte; M Jumbelic; G P Haas
Journal:  Prostate Cancer Prostatic Dis       Date:  2008-07-15       Impact factor: 5.554

9.  Saturation biopsies on autopsied prostates for detecting and characterizing prostate cancer.

Authors:  Nicolas B Delongchamps; Gustavo de la Roza; Richard Jones; Mary Jumbelic; Gabriel P Haas
Journal:  BJU Int       Date:  2008-08-01       Impact factor: 5.588

10.  Focal irreversible electroporation for prostate cancer: functional outcomes and short-term oncological control.

Authors:  F Ting; M Tran; M Böhm; A Siriwardana; P J Van Leeuwen; A M Haynes; W Delprado; R Shnier; P D Stricker
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-10-13       Impact factor: 5.554

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.